Healthcare Realty Trust (NYSE:HR - Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided EPS guidance of 1.570-1.610 for the period. The company issued revenue guidance of -.
Healthcare Realty Trust Trading Up 1.2%
HR traded up $0.21 during trading hours on Monday, hitting $16.75. The company's stock had a trading volume of 735,266 shares, compared to its average volume of 3,080,865. Healthcare Realty Trust has a fifty-two week low of $14.09 and a fifty-two week high of $18.90. The firm has a market capitalization of $5.88 billion, a PE ratio of -14.50 and a beta of 0.89. The company has a 50-day simple moving average of $15.43 and a 200 day simple moving average of $15.88.
Healthcare Realty Trust (NYSE:HR - Get Free Report) last posted its earnings results on Thursday, July 31st. The real estate investment trust reported $0.41 EPS for the quarter, beating the consensus estimate of $0.40 by $0.01. Healthcare Realty Trust had a negative return on equity of 7.70% and a negative net margin of 32.95%. The firm had revenue of $287.07 million for the quarter, compared to analysts' expectations of $290.83 million. During the same period last year, the firm earned $0.38 EPS. Research analysts expect that Healthcare Realty Trust will post 1.59 earnings per share for the current fiscal year.
Healthcare Realty Trust Cuts Dividend
The company also recently declared a quarterly dividend, which will be paid on Thursday, August 28th. Shareholders of record on Thursday, August 14th will be paid a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a yield of 5.7%. Healthcare Realty Trust's payout ratio is currently -107.83%.
Wall Street Analysts Forecast Growth
A number of brokerages have issued reports on HR. Wall Street Zen lowered Healthcare Realty Trust from a "hold" rating to a "sell" rating in a research note on Saturday, May 31st. Wedbush decreased their price target on Healthcare Realty Trust from $18.00 to $16.00 and set a "neutral" rating for the company in a research note on Monday, May 5th. JPMorgan Chase & Co. decreased their price target on Healthcare Realty Trust from $18.00 to $17.00 and set a "neutral" rating for the company in a research note on Thursday, June 26th. Finally, Wells Fargo & Company decreased their target price on Healthcare Realty Trust from $16.00 to $15.00 and set an "underweight" rating on the stock in a report on Monday, June 2nd. Two analysts have rated the stock with a sell rating and four have assigned a hold rating to the company's stock. According to MarketBeat.com, Healthcare Realty Trust presently has an average rating of "Hold" and an average price target of $16.40.
Read Our Latest Research Report on HR
Insider Activity at Healthcare Realty Trust
In other Healthcare Realty Trust news, Director Thomas N. Bohjalian bought 2,500 shares of the firm's stock in a transaction dated Tuesday, May 13th. The stock was acquired at an average price of $14.71 per share, with a total value of $36,775.00. Following the completion of the transaction, the director directly owned 56,502 shares in the company, valued at approximately $831,144.42. This represents a 4.63% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.37% of the stock is currently owned by company insiders.
Institutional Trading of Healthcare Realty Trust
An institutional investor recently bought a new position in Healthcare Realty Trust stock. Empowered Funds LLC acquired a new position in shares of Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 11,953 shares of the real estate investment trust's stock, valued at approximately $202,000.
Healthcare Realty Trust Company Profile
(
Get Free Report)
Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.
Recommended Stories

Before you consider Healthcare Realty Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthcare Realty Trust wasn't on the list.
While Healthcare Realty Trust currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.